Dr. Reddy's Labs in focus on re-launch of generic Suboxone film in US

Image
Capital Market
Last Updated : Feb 21 2019 | 9:04 AM IST

Dr. Reddy's Laboratories, along with its subsidiaries announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone (buprenorphine and naloxone) sublingual film, in the United States market. The announcement was made after market hours yesterday, 20 February 2019.

Moody's Investors Service has changed outlook on JSW Steel's corporate family rating (CFR) and senior unsecured bond rating to "Positive" from "Stable" while affirming rating at Ba2. The announcement was made after market hours yesterday, 20 February 2019.

Dynamatic Technologies has signed a Memorandum of Understanding with Joint-Stock Company (JSC) Russian Helicopters on Ka-226T Helicopter with an intent to build major structural assemblies for fuselage and aggregate assembly, sub-assemblies and detail parts fabrication. The announcement was made after market hours yesterday, 20 February 2019.

Zuari Agro Chemicals' board of directors approved raising of funds by way of issue of Compulsory Convertible Debentures to the existing shareholders of the company on a rights basis up to Rs 500 crore subject to all applicable statutory and regulatory approvals. The announcement was made after market hours yesterday, 20 February 2019.

Shipping Corporation of India has given physical delivery of its one bulk carrier "m.v. Tamilnadu", to its buyer. The announcement was made after market hours yesterday, 20 February 2019.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 21 2019 | 8:26 AM IST

Next Story